MLN9708, an investigational proteasome inhibitor, in patients (pts) with solid tumors: Updated phase I results.
David C. Smith
Research Funding - Millennium
Daniel Sullivan
No relevant relationships to disclose
Jeffrey R. Infante
No relevant relationships to disclose
John S. Kauh
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Millennium
Gordana Vlahovic
Consultant or Advisory Role - Genentech
John A. Thompson
Research Funding - Millennium
Neeraj Gupta
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
Alessandra Di Bacco
Employment or Leadership Position - Millennium
Guohui Liu
Employment or Leadership Position - Millennium
Thea Kalebic
Employment or Leadership Position - Millennium